======= C11orf30 ======= == Gene Information == * **Official Symbol**: EMSY * **Official Name**: EMSY transcriptional repressor, BRCA2 interacting * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56946|56946]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q7Z589|Q7Z589]] * **Interactions**: [[https://thebiogrid.org/search.php?search=C11orf30&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C11orf30|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608574|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Regulator which is able to repress transcription, possibly via its interaction with a multiprotein chromatin remodeling complex that modifies the chromatin. Its interaction with BRCA2 suggests that it may play a central role in the DNA repair function of BRCA2. As part of a histone H3-specific methyltransferase complex may mediate ligand-dependent transcriptional activation by nuclear hormone receptors. {ECO:0000269|PubMed:14651845, ECO:0000269|PubMed:19131338}. |ENT| |DNA repair| |chromatin organization| |DNA metabolic process| |cellular response to DNA damage stimulus| |protein homodimerization activity| |chromosome organization| |cellular response to stress| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp390|Pifithrin-alpha 20μM R07 exp390]]|-2.16| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-2.16| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-2.14| |[[:results:exp275|Citral 75μM R06 exp275]]|-2.06| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-1.97| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|-1.91| |[[:results:exp331|A-769662 20μM R07 exp331]]|-1.89| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|-1.87| |[[:results:exp392|PT-1 25μM R07 exp392]]|-1.82| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|-1.78| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|-1.77| |[[:results:exp42|BI-6727 0.001μM R01 exp42]]|-1.74| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|1.83| |[[:results:exp513|ONC212 0.15μM R08 exp513]]|1.84| |[[:results:exp360|Genistein 15μM R07 exp360]]|1.87| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|1.95| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|1.99| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4762 * **Expression level (log2 read counts)**: 5.51 {{:chemogenomics:nalm6 dist.png?nolink |}}